| SARS-CoV-2 infection triggers pro-atherogenic inflammatory responses in human coronary vessels N Eberhardt, MG Noval, R Kaur, L Amadori, M Gildea, S Sajja, D Das, ... Nature cardiovascular research 2 (10), 899-916, 2023 | 36 | 2023 |
| ERpS294 is a biomarker of ligand or mutational ERα activation and a breast cancer target for CDK2 inhibition GK Scott, D Chu, R Kaur, J Malato, DE Rothschild, K Frazier, ... Oncotarget 8 (48), 83432, 2017 | 14 | 2017 |
| Systems immunology-based drug repurposing framework to target inflammation in atherosclerosis L Amadori, C Calcagno, DM Fernandez, S Koplev, N Fernandez, R Kaur, ... Nature cardiovascular research 2 (6), 550-571, 2023 | 7 | 2023 |
| Loss of PRMT2 in myeloid cells in normoglycemic mice phenocopies impaired regression of atherosclerosis in diabetic mice B Vurusaner, P Thevkar-Nages, R Kaur, C Giannarelli, MJ Garabedian, ... Scientific Reports 12 (1), 12031, 2022 | 7 | 2022 |
| The IRG1–itaconate axis protects from cholesterol-induced inflammation and atherosclerosis Y Cyr, FK Bozal, JG Barcia Durán, AAC Newman, L Amadori, P Smyrnis, ... Proceedings of the National Academy of Sciences 121 (15), e2400675121, 2024 | 2 | 2024 |
| Single-Cell Driven Drug Repositioning Approach Identifies a New Anti-Atherosclerotic Compound Targeting Myeloid Cells L Amadori, C Calcagno, DM Fernandez, S Koplev, NF Fernandez, R Kaur, ... Circulation 144 (Suppl_1), A13468-A13468, 2021 | 2 | 2021 |
| Assessment of the Usability of SARS-CoV-2 Self Tests in a Peer-Assisted Model among Factory Workers in Bengaluru, India MR Pydi, P Stankard, N Parikh, P Ranawat, R Kaur, S AG, A Chaudhuri, ... medRxiv, 2023.11. 20.23298784, 2023 | 1 | 2023 |
| Suggested searches E Axell, J Hu, M Lindberg, AJ Dear, L Ortigosa-Pascual, EA Andrzejewska, ... Perspective, 2024 | | 2024 |
| IBU RUMAH TANGGA SEBAGAI INFLUENCER (Studi Fenomenologi Ibu Rumah Tangga sebagai Influencer pada Media Sosial Instagram) FV Singh PERPUSTAKAAN, 2023 | | 2023 |
| Publisher Correction: Systems immunology-based drug repurposing framework to target inflammation in atherosclerosis L Amadori, C Calcagno, DM Fernandez, S Koplev, N Fernandez, R Kaur, ... Nature Cardiovascular Research 2 (8), 793-793, 2023 | | 2023 |
| Lipid Regulation of Senescent Effector CD8 T Cells in Type 2 Diabetes N Eberhardt, R Kaur, M Gildea, D Das, L Amadori, D Fernandez, ... Arteriosclerosis, Thrombosis, and Vascular Biology 43 (Suppl_1), A105-A105, 2023 | | 2023 |
| Single cell mapping identifies expansion of Cytotoxic CD4 T cells in the atherosclerotic plaque of subjects with Type 2 Diabetes D Das, M Gildea, N Eberhardt, R Kaur, D Fernandez, L Amadori, S Sajja, ... The Journal of Immunology 210 (1_Supplement), 234.17-234.17, 2023 | | 2023 |
| Knowledge, attitudes, practices and perceptions around SARS CoV rapid antigen self-tests among urban poor communities of Mohammadpur and Bangalore, India N Parikh, SB Syam, R Kaur, A Chaudhuri, AG Shankar Population Medicine 5 (Supplement), 2023 | | 2023 |
| System Gene Regulatory Network-Based Drug Repurposing Combined With Preclinical Molecular Imaging Identifies Anti-Atherosclerotic Properties of Auranofin L Amadori, C Calcagno, R Kaur, PS Chong, S Sajja, R Shamailova, ... Circulation 146 (Suppl_1), A13560-A13560, 2022 | | 2022 |
| Heterogeneous Populations of Cytotoxic CD4 T Cells Are Expanded in Atherosclerotic Plaques of Patients With Type 2 Diabetes D Das, R Kaur, M Gildea, N Eberhardt, D Fernandez, L Amadori, S Sajja, ... Circulation 146 (Suppl_1), A13609-A13609, 2022 | | 2022 |
| Senescent CD8 T Cells are Enriched in Atherosclerotic Plaques From Patients With Type 2 Diabetes and Their Circulating Levels Are Normalized by Intensive Lipid Lowering N Eberhardt, R Kaur, M Gildea, D Das, L Amadori, D Fernandez, ... Circulation 146 (Suppl_1), A12926-A12926, 2022 | | 2022 |
| ER alpha phosphorylation at pS294: A biomarker of ligand or mutational (Y537S, D538G) activation, and a receptor target for CDK2 inhibition CC Benz, GK Scott, D Chu, R Kaur, M Muthurajah, D Rothschild, K Frazier, ... CANCER RESEARCH 76, 2016 | | 2016 |
| Abstract PD2-04: ERα phosphorylation at pS294: A biomarker of ligand or mutational (Y537S, D538G) activation, and a receptor target for CDK2 inhibition CC Benz, GK Scott, D Chu, R Kaur, M Muthurajah, D Rothschild, K Frazier, ... Cancer Research 76 (4_Supplement), PD2-04-PD2-04, 2016 | | 2016 |
| Inhibition of CDK1/2 but not CDK4/6 cooperates with tamoxifen to induce apoptosis GK Scott, D Rothschild, R Kaur, C Benz Cancer Research 74 (19_Supplement), 4555-4555, 2014 | | 2014 |
| Inhibition of Cdk9 blocks ligand induced phosphorylation of Estrogen receptor alpha at Ser294. GK Scott, R Kaur, D Rothschild, CC Benz Cancer Research 73 (8_Supplement), 3571-3571, 2013 | | 2013 |
